Pharmaceutical

Top 20 biopharma companies’ market caps rise 1.7% over 2024 amid policy

The top 20 biopharmaceutical companies experienced mixed performance in 2024 amid a dynamic landscape influenced by various factors.

Feb 1, 2025 - 06:00
Top 20 biopharma companies’ market caps rise 1.7% over 2024 amid policy
The top 20 biopharmaceutical companies experienced mixed performance in 2024 amid a dynamic landscape influenced by various factors.
Read the original article

Tags:

Previous Article

Sanofi reports Q4 2024 increase in net income to $916m

Next Article

NHS England to offer Casgevy for sickle cell disease patients

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Vittoria’s CAR-T therapy secures clinical approval amid FDA scrutiny on sector

Vittoria’s CAR-T therapy secures clinical approval amid...

Dec 8, 2023

U.S. births in 2022 didn’t return to pre-pandemic levels

U.S. births in 2022 didn’t return to pre-pandemic levels

Jun 2, 2023

Opinion: A bipartisan opportunity to strengthen America’s pandemic security

Opinion: A bipartisan opportunity to strengthen America...

Jul 12, 2023